Form Type: 4

SEC EDGAR Link
Acccession Number:0001104659-20-038881
Date:2020-03-24
Issuer: APREA THERAPEUTICS, INC. (APRE)
Original Submission Date:

Reporting Person:

KORBEL GREGORY ALAN
535 BOYLSTON STREET
BOSTON, MA 02116

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 35.5 2020-03-24 deemed execution date A 12,800 (a) 2030-03-24 common stock 12,800 $35.50 12,800 direct
Footnotes
IDfootnote
f1 twenty-five percent of these options vest on march 24, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Elevate your investments